labcorp america hold
labcorp america lead provid diagnost test inform servic
result top expect guidanc rais diagnost
organ revenu growth better expect despit volum impact
harsh winter drug develop busi acceler plan
integr chiltern continu go smoothli headlin ep
guid suggest chang de facto increas sinc previous
contempl advers impact conserv
manag team guid wide rang potenti outcom earli
year guidanc rais encourag boost confid underli busi
trend anoth year gener provid wide rang
capit alloc option maintain buy rate price target
ep well consensu estim
estim major beat versu model function lower
forecast tax rate exclud amort special charg vs
result reflect account rule y/i comparison
discuss contempl restat year ago result revenu
beat estim consensu
labcorp diagnost revenu beat
test volum increas nice forecast upsid
organ volum growth vs estim despit
drag sever winter weather vs estim
revenu per requisit grew vs estim
continu benefit price partial off-set lower reimburs
pama impact consist past commentari
foreign currenc provid bp boost growth slightli
covanc drug develop revenu y/i also
estim constant currenc basi revenu increas
fx provid bp tailwind quarter constant currenc increas
function acceler organ growth chiltern acquisit
